Psychemedics Basic EPS 2010-2024 | PMD
Psychemedics basic eps from 2010 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
Psychemedics Annual Basic EPS |
2023 |
$-0.72 |
2022 |
$-0.19 |
2021 |
$-0.12 |
2020 |
$-0.70 |
2019 |
$0.28 |
2018 |
$0.83 |
2017 |
$1.12 |
2016 |
$1.23 |
2015 |
$0.28 |
2014 |
$0.60 |
2013 |
$0.72 |
2012 |
$0.57 |
2011 |
$0.67 |
2010 |
$0.50 |
2009 |
$0.29 |
Psychemedics Quarterly Basic EPS |
2024-06-30 |
$-0.14 |
2024-03-31 |
$-0.12 |
2023-12-31 |
$-0.16 |
2023-09-30 |
$-0.36 |
2023-06-30 |
$-0.13 |
2023-03-31 |
$-0.07 |
2022-12-31 |
$-0.12 |
2022-09-30 |
$-0.02 |
2022-06-30 |
$-0.06 |
2022-03-31 |
$0.01 |
2021-12-31 |
$-0.28 |
2021-09-30 |
$0.13 |
2021-06-30 |
$0.02 |
2021-03-31 |
$0.01 |
2020-12-31 |
$-0.10 |
2020-09-30 |
$-0.20 |
2020-06-30 |
$-0.37 |
2020-03-31 |
$-0.03 |
2019-12-31 |
$-0.09 |
2019-09-30 |
$0.12 |
2019-06-30 |
$0.14 |
2019-03-31 |
$0.11 |
2018-12-31 |
$0.16 |
2018-09-30 |
$0.23 |
2018-06-30 |
$0.21 |
2018-03-31 |
$0.23 |
2017-12-31 |
$0.43 |
2017-09-30 |
$0.25 |
2017-06-30 |
$0.17 |
2017-03-31 |
$0.27 |
2016-12-31 |
$0.43 |
2016-09-30 |
$0.50 |
2016-06-30 |
$0.30 |
2016-03-31 |
$0.00 |
2015-12-31 |
$0.03 |
2015-09-30 |
$0.15 |
2015-06-30 |
$0.05 |
2015-03-31 |
$0.05 |
2014-12-31 |
$0.13 |
2014-09-30 |
$0.17 |
2014-06-30 |
$0.16 |
2014-03-31 |
$0.14 |
2013-12-31 |
$0.16 |
2013-09-30 |
$0.20 |
2013-06-30 |
$0.20 |
2013-03-31 |
$0.16 |
2012-12-31 |
$0.05 |
2012-09-30 |
$0.17 |
2012-06-30 |
$0.19 |
2012-03-31 |
$0.16 |
2011-12-31 |
$0.09 |
2011-09-30 |
$0.21 |
2011-06-30 |
$0.21 |
2011-03-31 |
$0.16 |
2010-12-31 |
$0.07 |
2010-09-30 |
$0.16 |
2010-06-30 |
$0.17 |
2010-03-31 |
$0.10 |
2009-12-31 |
$0.10 |
2009-09-30 |
$0.15 |
2009-06-30 |
$0.03 |
2009-03-31 |
$0.01 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Outpatient & Home Care |
$0.014B |
$0.022B |
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
|